Remove 2025 Remove Pharmaceutical manufacturing Remove Prescription
article thumbnail

10 New Solutions, Strategies, and Devices to Boost Adherence

PM360

billion in 2025. The combined solution enables health plans and self-insured employers to realize immediate pharmacy cost savings and near-term medical cost reductions by integrating Levrx’s plan-specific and real-time prescription insights into the Adhere Platform medication optimization offerings. from 2021 and reach $4.2

article thumbnail

CMS enters drug price negotiation arena in sea change for industry

Clarivate

Although the reported negotiated prices may ignore the real-world role of contracting by manufacturers and private payers over formulary placement, the reported prices nonetheless are likely to have downstream impacts on how private payers reimburse these therapies and their competitors. These ten drugs cost Medicare Part D nearly $46.8